“The Oxford COVID-19 Vaccine: a vaccine for the world” has won a Vice-Chancellor’s Innovation & Engagement Award. The team behind the vaccine included Professor Gavin Screaton, Professorial Fellow and Head of the Medical Sciences Division.

Professor Screaton‘s research focuses on the immunology and immunopathology of infectious diseases such as HIV, SARS and Dengue. His research includes a paper published in The Lancet analysing the impact of the Omicron COVID-19 variant on antibodies generated by vaccination.

He is a Fellow of the Academy of Medical Sciences and the Royal College of Physicians, a member of the Association of Physicians, the MRC Strategy Board and the prestigious Henry Kunkel Society. He was also made a Founder Senior Investigator at the National Institute for Health Research. He is a Non-Executive Director of Oxford University Hospitals NHS Foundation Trust.

Professor Screaton discussed Oxford’s response to COVID-19 in the early stages of the pandemic in the University’s COVID Conversations series.

You can find out more about the Vice-Chancellor’s Innovation & Engagement Awards here.

Published: 27 October 2022

Explore Univ on social media